摘要
目的 :评价 654- 2软膏对新生儿硬肿症的治疗效果。方法 :随机将 70例新生儿硬肿症患儿分为 654- 2组及对照组。结果 :t检验及 Ridit检验表明 ,654- 2组与对照组在疗效方面存在非常显著差异。结论 :654- 2软膏外用治疗新生儿硬肿症具有显效快、疗效好、操作简单、无副作用的优点 ,且价格便宜 。
Objective:To evaluate the clinical effectiveness of unguentum anisodamini hydrobromidum therapy for children with newborn scleredema.Methods:The children who suffered from newborn scleredema had been randomly allocated into two groups :unguentum anisodamini hydrobromidum treatment group and control group.[WT5HZ]Results:[WT5BZ]There is distinctive differences on the efficacy between the observed group and the control group on the efficacy beiween the observed group and the control group on the basis of t test and Ridit analysis.Conclusion:unguentum anisodamini hydrobromidum is an effective treatment for newborn seleredema,it possesses the advantage of short time producing desired result,certainly cougative effect ,simple operation,no side effect,lower price and suitable for clinical spreading and application.
出处
《河北医学》
CAS
2000年第12期1063-1064,共2页
Hebei Medicine
关键词
硬肿症
新生儿
654-2
Scleredema
Newborn
Unguentum anisodamini hydrobromidum